133 related articles for article (PubMed ID: 4661188)
1. [Treatment of essential arterial hypertension with spironolactone: its value in the detection of primary hyperaldosteronism and prediction of its efficacy].
Fournier A; Nakache JP; Salmon D; Kazandjian M; Baulon A; Legrand JC; Menard J; Lagrue G
J Urol Nephrol (Paris); 1972 Dec; 78(12):1023-7. PubMed ID: 4661188
[No Abstract] [Full Text] [Related]
2. [Treatment of essential arterial hypertension with spironolactone: its value for the screening of primary hyperaldosteronism and prediction of its efficacy].
Fournier A; Lagrue G; Nakache JP; Salmon D; Kazandjian M; Baulon A; Legrand JC; Menard J
Therapeutique; 1973 Feb; 49(2):127-30. PubMed ID: 4732774
[No Abstract] [Full Text] [Related]
3. Value of the spironolactone test in the diagnosis of primary hyperaldosteronism.
Jessurun RF; Struyvenberg A; Dorhout Mees EJ
Neth J Med; 1979; 22(1):23-6. PubMed ID: 418941
[No Abstract] [Full Text] [Related]
4. Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
Salti IS; Stiefel M; Ruse JL; Laidlaw JC
Can Med Assoc J; 1969 Jul; 101(1):1-10. PubMed ID: 5793351
[No Abstract] [Full Text] [Related]
5. Intravenously administered chlorothiazide in diagnostic evaluation of hypertensive disease.
McGuffin WL; Gunnells JC
Arch Intern Med; 1969 Feb; 123(2):124-30. PubMed ID: 5763614
[No Abstract] [Full Text] [Related]
6. [Spironolactone in essential hypertension associated with abnormal aldosterone regulation and in Conn's syndrome (author's transl)].
Wambach G; Helber A; Bönner G; Hummerich W; Meurer KA; Kaufmann W
Dtsch Med Wochenschr; 1980 May; 105(18):647-51. PubMed ID: 7371530
[No Abstract] [Full Text] [Related]
7. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
Jose A; Kaplan NM
Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
[No Abstract] [Full Text] [Related]
8. [Normoaldosterone spironolactone sensitive hypertension].
Krysiak R; Okopień B; Herman ZS
Pol Merkur Lekarski; 2006 Apr; 20(118):427-9. PubMed ID: 16886567
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between sweat, sodium and potassium excretion and the renin-angiotensin-aldosterone system in hypertension].
Rosset G
Schweiz Med Wochenschr; 1973 Mar; 103(12):439-48. PubMed ID: 4697590
[No Abstract] [Full Text] [Related]
10. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
Uchida K; Morimoto S; Takeda R; Murakami M
Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
[No Abstract] [Full Text] [Related]
11. [The value of studying essential arterial hypertension with isotopic methods. Their application in arterial hypertension with low renin level].
Olmer M; Salvadori JM; Paulin R; Sommer A; Marion J
Nouv Presse Med; 1974 Feb; 3(5):233-6. PubMed ID: 4819942
[No Abstract] [Full Text] [Related]
12. [The role of anti-aldosterones in the treatment of arterial hypertension].
Corvol P; Ménard J; Milliez P
Rev Prat; 1973 Feb; 23(9):671-2 passim. PubMed ID: 4733167
[No Abstract] [Full Text] [Related]
13. Estimation of plasma potassium, renin and aldosterone in the diagnosis of primary hyperaldosteronism; the role of spironolactone in the treatment of this syndrome.
Brown JJ; Chinn RH; Dusterdieck G; Fraser R; Lever AF; Robertson JI; Tree M
J Endocrinol; 1969 Jan; 43(1):iv-v. PubMed ID: 5773780
[No Abstract] [Full Text] [Related]
14. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension.
Sharabi Y; Adler E; Shamis A; Nussinovitch N; Markovitz A; Grossman E
Am J Hypertens; 2006 Jul; 19(7):750-5. PubMed ID: 16814132
[TBL] [Abstract][Full Text] [Related]
15. The syndrome of primary aldosteronism.
George JM; Wright L; Bell NH; Bartter FC
Am J Med; 1970 Mar; 48(3):343-56. PubMed ID: 5435648
[No Abstract] [Full Text] [Related]
16. [Primary hyperaldosteronism. Description of a clinical case].
Bianchi G; Campolo L; Alè G; Sala G
Minerva Med; 1969 Apr; 60(33):1604-14. PubMed ID: 5772244
[No Abstract] [Full Text] [Related]
17. Hypertension and hyperaldosteronism with low plasma renin concentration: analysis of a series of eighty-two patients.
Brown JJ; Chinn RH; Düsterdieck GO; Fraser R; Gleadle RH; Lever AF; Robertson JI; Tree M
Proc R Soc Med; 1969 Dec; 62(12):1258-60. PubMed ID: 5363111
[No Abstract] [Full Text] [Related]
18. Test for pathologic secretion of aldosterone.
Birchall R; Batson HM
JAMA; 1968 Nov; 206(9):2114-7. PubMed ID: 5754932
[No Abstract] [Full Text] [Related]
19. Hyperaldosteronism in hypertensive congenital adrenal hyperplasia.
Lim NY; Mimica N; Dingman JF
J Clin Endocrinol Metab; 1969 Dec; 29(12):1564-8. PubMed ID: 4310498
[No Abstract] [Full Text] [Related]
20. Primary aldosteronism. Review of diagnostic tests and 15 cases.
Koppes G
J Kans Med Soc; 1972 May; 73(5):259-71 passim. PubMed ID: 5026873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
